Category: Influenza
Global Influenza
-
2024 Global Forecast for Influenza Vaccination Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Seasonal Influenza - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV, Others), By End Use (Hospitals, Clinics, Others), By Region, and By Competition
... Competition Global Infectious Disease Therapeutics Market was valued at USD 67.04 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.00% through 2029. The Global Infectious ... Read More
-
Global Seasonal Influenza Vaccines Therapeutics Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Seasonal Influenza Vaccines Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Influenza Drugs and Vaccines Market Growth 2024-2030
... downstream market, the Influenza Drugs and Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Influenza Vaccines Global Market Report 2024
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Influenza Vaccines Market – By Vaccine Type (Inactivated, Live Attenuated), Indication (Quadrivalent, Trivalent), Technology (Egg-based, Cell-based), Flu Type (Seasonal, Pandemic), Age Group, Route of Administration, End-user, Global Forecast 2024 – 2032
... expected to witness 6.8% CAGR between 2024 and 2032, driven by increasing prevalence of influenza viruses worldwide. As per WHO, annually, approximately 1 billion cases of seasonal influenza occur, with 3–5 million cases classified as ... Read More
-
Global Influenza Vaccines Market and Forecasts 2024 – 2032
... a CAGR 7.2% during the forecast period. Several factors are contributing to the growth of the influenza vaccines market. Here are some key factors: Increasing Awareness and Education Government Initiatives and Vaccination Programs Rising Incidence ... Read More
-
Influenza Diagnostics Market by Test Type (Cell Culture, Rapid Influenza Diagnostic Tests, Reverse Transcription-Polymerase Chain Reaction), End-User (Hospitals, Laboratories, Point-Of-Care Testing) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 9.86% to reach USD 2.32 billion by 2030. Global Influenza Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Conjugate Vaccine Market by Type (Monovalent, Multivalent), Indication (Diphtheria & Pertussis, Influenza, Meningococcal), Pathogen Type, End-User - Global Forecast 2024-2030
... to reach USD 43.92 billion in 2024, at a CAGR 10.81% to reach USD 81.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Conjugate Vaccine Market. It offers ... Read More
-
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Global Forecast 2024-2030
... 7.92 billion in 2023 and expected to reach USD 8.61 billion in 2024, at a CAGR 9.01% to reach USD 14.49 billion by 2030. Global Influenza Vaccine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Global Influenza Treatment Market Size study & Forecast, by Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate, Others) by Route of Administration (Oral, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2023-2030
... 2023-2030 Global Influenza Treatment Market is valued approximately USD 5.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.18% over the forecast period 2023-2030. Influenza treatment refers ... Read More
-
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The global human ... Read More
-
Influenza Diagnostic Global Market Report 2024
... Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes Covering: F. ... Read More
-
Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End Use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2023 - 2030
... Trends The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, registering a CAGR of 3.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 9.8 Billion by 2028, exhibiting a CAGR of 7.93% during 2022-2028. The increasing awareness about the importance of vaccination, rising prevalence of influenza, and favorable government initiatives promoting vaccination programs are some of ... Read More
-
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) & Region - Global Forecast to 2028
... The global vaccines market size is projected to reach USD 93.8 billion by 2028 from USD 77.6 billion in 2023, at a CAGR of 3.9% during the forecast period. Factors such as high incidence of ... Read More
-
Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030
... (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030 Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Cell Line (In-vitro, In-Vivo), Type (Adeno-Associated Virus, Adenovirus, Lentivirus), Transfection, Indication, Workflow, Application, End User - Global Forecast 2023-2030
... is projected to reach USD 7.32 billion by 2030 from USD 1.20 billion in 2022, at a CAGR of 25.30% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts ... Read More
-
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032
... and B cause human disease of public health concern (WHO, 2023). Influenza transmission occurs when people with the flu cough, sneeze, or talk, thereby disseminating droplets. These droplets can land in the mouths or noses ... Read More
-
Infectious Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Service (Assays, Kits, & Reagents, Instruments, Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others), By End User (Hospital and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others), By Region and Competition
... an anticipated Compound Annual Growth Rate (CAGR) of 4.89% through 2028. Losartan is a medication primarily prescribed for the treatment of high blood pressure (hypertension) and specific heart conditions. It falls under the category of ... Read More
-
Global Influenza Vaccine Market: Analysis by Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028
... Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 The influenza vaccine, often referred to as the flu ... Read More
-
Global Respiratory Syncytial Virus Diagnostic Market 2023-2030
... Antibody Method, Immunoassays and Others), and by End-Users (Hospitals, Clinics, and Laboratories), Forecast Period (2023-2030) The global respiratory syncytial virus diagnostic market is anticipated to grow at a significant CAGR of 6.5% during the forecast ... Read More
-
Global Epstein-Barr Virus Diagnosis and Treatment Market 2023-2030
... Other Drugs), Forecast Period (2023-2030) The global Epstein - Barr virus diagnosis and treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2023-2030). The considerable prevalence of the ... Read More
Research Assistance
